Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Cash from Operations Growth (1y) (2018 - 2026)

Analysis

Catheter Precision (VTAK) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 21.54%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 48.31%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 64.80%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 13.50%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 14.62%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 124.64%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 0.99%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -11.16%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn -12.60%
10 Catheter Precision 553,488.01 -1.71 Mn 98,000.00 -28.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -28.15%
Mar 31, 2026 -19.76%
Dec 31, 2025 47.63%
Sep 30, 2025 20.56%
Jun 30, 2025 -33.35%
Mar 31, 2025 -20.39%
Dec 31, 2024 -51.61%
Sep 30, 2024 -51.26%
Jun 30, 2024 64.99%
Mar 31, 2024 83.89%
Dec 31, 2023 37.55%
Sep 30, 2023 63.15%
Jun 30, 2023 19.32%
Mar 31, 2023 -40.66%
Dec 31, 2022 47.03%
Sep 30, 2022 31.17%
Jun 30, 2022 9.26%
Mar 31, 2022 -6.08%
Dec 31, 2021 39.34%
Sep 30, 2021 -19.32%